You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
鷹瞳科技傳下月赴港尋求通過聆訊 集資至少23.3億
格隆匯 08-27 17:15
格隆匯8月27日丨據香港經濟日報,今年六月遞交上市申請的鷹瞳科技據報將在下月赴港闖關尋求通過上市聆訊,公司計劃集資3億至5億美元(摺合約23.3億至38.8億港元)。鷹瞳科技主要提供人工智能視網膜影像識別的早期檢測、輔助診斷及健康風險評估解決方案,擁有中國首款用於協助診斷糖尿病視網膜病變的軟件Airdoc-AIFUNDUS (1.0),瑞銀及中信證券為聯席保薦人。該公司在2015年先後合併進行7輪融資,包括中國平安(2318.HK)、復星集團、清池資本、奧博資本等均有份等參與投資。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account